Interindividual differences in phytochemical metabolism and disposition

Seminars in Cancer Biology

Volumn 17, Issue 5, 2007, Pages 347-353

  Lampe, Johanna W ^a   Chang, Jyh Lurn ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Genetic polymorphism; Gut bacteria; Interindividual variation; Phase II biotransformation enzyme; Phytochemical

Indexed keywords

CANCER RISK; DIETARY INTAKE; HUMAN; INDIVIDUALITY; MALIGNANT NEOPLASTIC DISEASE; METABOLISM; NONHUMAN; PHYTOCHEMISTRY; PHYTONUTRIENT; REVIEW; VEGETABLE;

BACTERIA; HUMANS; INTESTINES; METABOLIC DETOXICATION, PHASE II; PLANT PREPARATIONS; POLYMORPHISM, GENETIC; TRANSFERASES;

EID: 34548445077     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2007.05.003     Document Type: Review

References (67)

1. Liu R.H. Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutr 134 12 Suppl (2004) 3479S-3485S
2. Fresco P., Borges F., Diniz C., and Marques M.P. New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26 6 (2006) 747-766
3. Kar P., Laight D., Shaw K.M., and Cummings M.H. Flavonoid-rich grapeseed extracts: a new approach in high cardiovascular risk patients?. Int J Clin Pract 60 11 (2006) 1484-1492
4. Nichenametla S.N., Taruscio T.G., Barney D.L., and Exon J.H. A review of the effects and mechanisms of polyphenolics in cancer. Crit Rev Food Sci Nutr 46 2 (2006) 161-183
5. Rao A.V., and Rao L.G. Carotenoids and human health. Pharmacol Res 55 3 (2007) 207-216
6. Holst B., and Williamson G. A critical review of the bioavailability of glucosinolates and related compounds. Nat Prod Rep 21 3 (2004) 425-447
7. Manach C., Williamson G., Morand C., Scalbert A., and Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81 1 Suppl (2005) 230S-242S
8. Erlund I., Meririnne E., Alfthan G., and Aro A. Plasma kinetics and urinary excretion of the flavanones naringenin and hesperetin in humans after ingestion of orange juice and grapefruit juice. J Nutr 131 2 (2001) 235-241
9. Kuijsten A., Arts I.C., Vree T.B., and Hollman P.C. Pharmacokinetics of enterolignans in healthy men and women consuming a single dose of secoisolariciresinol diglucoside. J Nutr 135 4 (2005) 795-801
10. Shephard S.E., Zogg M., Burg G., and Panizzon R.G. Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood. Arch Dermatol Res 291 9 (1999) 491-499
11. Undevia S.D., Gomez-Abuin G., and Ratain M.J. Pharmacokinetic variability of anticancer agents. Nat Rev Cancer 5 6 (2005) 447-458
12. Brand W., Schutte M.E., Williamson G., van Zanden J.J., Cnubben N.H., Groten J.P., et al. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients. Biomed Pharmacother 60 9 (2006) 508-519
13. Sesink A.L., Arts I.C., de Boer V.C., Breedveld P., Schellens J.H., Hollman P.C., et al. Breast cancer resistance protein (Bcrp1/Abcg2) limits net intestinal uptake of quercetin in rats by facilitating apical efflux of glucuronides. Mol Pharmacol 67 6 (2005) 1999-2006
14. Wang Y., Cao J., and Zeng S. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin. J Pharm Pharmacol 57 6 (2005) 751-758
15. Cascorbi I. Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs. Pharmacol Ther 112 2 (2006) 457-473
16. Ieiri I., Takane H., Hirota T., Otsubo K., and Higuchi S. Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy. Expert Opin Drug Metab Toxicol 2 5 (2006) 651-674
17. Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Lett 234 1 (2006) 4-33
18. Jacobs E., Kulling S.E., and Metzler M. Novel metabolites of the mammalian lignans enterolactone and enterodiol in human urine. J Steroid Biochem Mol Biol 68 5-6 (1999) 211-218
19. Jacobs E., and Metzler M. Oxidative metabolism of the mammalian lignans enterolactone and enterodiol by rat, pig, and human liver microsomes. J Agric Food Chem 47 3 (1999) 1071-1077
20. Otake Y., and Walle T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metab Dispos 30 2 (2002) 103-105
21. Piver B., Fer M., Vitrac X., Merillon J.M., Dreano Y., Berthou F., et al. Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol 68 4 (2004) 773-782
22. Potter G.A., Patterson L.H., Wanogho E., Perry P.J., Butler P.C., Ijaz T., et al. The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br J Cancer 86 5 (2002) 774-778
23. Kassahun K., Davis M., Hu P., Martin B., and Baillie T. Biotransformation of the naturally occurring isothiocyanate sulforaphane in the rat: identification of phase I metabolites and glutathione conjugates. Chem Res Toxicol 10 11 (1997) 1228-1233
24. Miller N., and Whelan J. Random mutagenesis of human estrogen receptor ligand binding domain identifies mutations that decrease sensitivity to estradiol and increase sensitivity to a diphenol indene-ol compound: basis for a regulatable expression system. J Steroid Biochem Mol Biol 64 3-4 (1998) 129-135
25. Murphy L.C., Dotzlaw H., Leygue E., Douglas D., Coutts A., and Watson P.H. Estrogen receptor variants and mutations. J Steroid Biochem Mol Biol 62 5-6 (1997) 363-372
26. Oehler M.K., Greschik H., Fischer D.C., Tong X., Schuele R., and Kieback D.G. Functional characterization of somatic point mutations of the human estrogen receptor alpha (hERalpha) in adenomyosis uteri. Mol Hum Reprod 10 12 (2004) 853-860
27. Goldin B.R. In situ bacterial metabolism and colon mutagens. Annu Rev Microbiol 40 (1986) 367-393
28. Keppler K., and Humpf H.U. Metabolism of anthocyanins and their phenolic degradation products by the intestinal microflora. Bioorg Med Chem 13 17 (2005) 5195-5205
29. Rechner A.R., Smith M.A., Kuhnle G., Gibson G.R., Debnam E.S., Srai S.K., et al. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 36 2 (2004) 212-225
30. Atkinson C., Frankenfeld C.L., and Lampe J.W. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230 3 (2005) 155-170
31. Adlercreutz H., Fotsis T., Bannwart C., Wahala K., Makela T., Brunow G., et al. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets. J Steroid Biochem 25 5B (1986) 791-797
32. Adlercreutz H., Fotsis T., Heikkinen R., Dwyer J.T., Goldin B.R., Gorbach S.L., et al. Diet and urinary excretion of lignans in female subjects. Med Biol 59 4 (1981) 259-261
33. Cunnane S.C., Hamadeh M.J., Liede A.C., Thompson L.U., Wolever T.M., and Jenkins D.J. Nutritional attributes of traditional flaxseed in healthy young adults. Am J Clin Nutr 61 1 (1995) 62-68
34. Hutchins A.M., Martini M.C., Olson B.A., Thomas W., and Slavin J.L. Flaxseed consumption influences endogenous hormone concentrations in postmenopausal women. Nutr Cancer 39 1 (2001) 58-65
35. Lampe J.W., Martini M.C., Kurzer M.S., Adlercreutz H., and Slavin J.L. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder. Am J Clin Nutr 60 1 (1994) 122-128
36. Nesbitt P.D., Lam Y., and Thompson L.U. Human metabolism of mammalian lignan precursors in raw and processed flaxseed. Am J Clin Nutr 69 3 (1999) 549-555
37. Rowland I., Faughnan M., Hoey L., Wahala K., Williamson G., and Cassidy A. Bioavailability of phyto-oestrogens. Br J Nutr 89 Suppl 1 (2003) S45-S58
38. Heinonen S., Nurmi T., Liukkonen K., Poutanen K., Wahala K., Deyama T., et al. In vitro metabolism of plant lignans: new precursors of mammalian lignans enterolactone and enterodiol. J Agric Food Chem 49 7 (2001) 3178-3186
39. Setchell K.D.R., and Adlercreutz H. In: Rowland I. (Ed). Role of the gut flora in toxicity and cancer (1988), Academic Press, London 316-345
40. Wang L.Q., Meselhy M.R., Li Y., Qin G.W., and Hattori M. Human intestinal bacteria capable of transforming secoisolariciresinol diglucoside to mammalian lignans, enterodiol and enterolactone. Chem Pharm Bull (Tokyo) 48 11 (2000) 1606-1610
41. Possemiers S., Heyerick A., Robbens V., De Keukeleire D., and Verstraete W. Activation of proestrogens from hops (Humulus lupulus L.) by intestinal microbiota; conversion of isoxanthohumol into 8-prenylnaringenin. J Agric Food Chem 53 16 (2005) 6281-6288
42. Possemiers S., Bolca S., Grootaert C., Heyerick A., Decroos K., Dhooge W., et al. The prenylflavonoid isoxanthohumol from hops (Humulus lupulus L.) is activated into the potent phytoestrogen 8-prenylnaringenin in vitro and in the human intestine. J Nutr 136 7 (2006) 1862-1867
43. Getahun S.M., and Chung F.L. Conversion of glucosinolates to isothiocyanates in humans after ingestion of cooked watercress. Cancer Epidemiol Biomarkers Prev 8 5 (1999) 447-451
44. Kensler T.W., Chen J.G., Egner P.A., Fahey J.W., Jacobson L.P., Stephenson K.K., et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People's Republic of China. Cancer Epidemiol Biomarkers Prev 14 11 Pt 1 (2005) 2605-2613
45. Conaway C.C., Jiao D., Kohri T., Liebes L., and Chung F.L. Disposition and pharmacokinetics of phenethyl isothiocyanate and 6-phenylhexyl isothiocyanate in F344 rats. Drug Metab Dispos 27 1 (1999) 13-20
46. Hayes J.D., Flanagan J.U., and Jowsey I.R. Glutathione transferases. Annu Rev Pharmacol Toxicol 45 (2005) 51-88
47. Kolm R.H., Danielson U.H., Zhang Y., Talalay P., and Mannervik B. Isothiocyanates as substrates for human glutathione transferases: structure-activity studies. Biochem J 311 Pt 2 (1995) 453-459
48. Zhang Y., Kolm R.H., Mannervik B., and Talalay P. Reversible conjugation of isothiocyanates with glutathione catalyzed by human glutathione transferases. Biochem Biophys Res Commun 206 2 (1995) 748-755
49. Seow A., Vainio H., and Yu M.C. Effect of glutathione-S-transferase polymorphisms on the cancer preventive potential of isothiocyanates: an epidemiological perspective. Mutat Res 592 1-2 (2005) 58-67
50. Seow A., Shi C.Y., Chung F.L., Jiao D., Hankin J.H., Lee H.P., et al. Urinary total isothiocyanate (ITC) in a population-based sample of middle-aged and older Chinese in Singapore: relationship with dietary total ITC and glutathione S-transferase M1/T1/P1 genotypes. Cancer Epidemiol Biomarkers Prev 7 9 (1998) 775-781
51. Gasper A.V., Al-Janobi A., Smith J.A., Bacon J.R., Fortun P., Atherton C., et al. Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 82 6 (2005) 1283-1291
52. Steck S.E., Gammon M.D., Hebert J.R., Wall D.E., and Zeisel S.H. GSTM1, GSTT1, GSTP1, and GSTA1 polymorphisms and urinary isothiocyanate metabolites following broccoli consumption in humans. J Nutr 137 4 (2007) 904-909
53. Probst-Hensch N.M., Tannenbaum S.R., Chan K.K., Coetzee G.A., Ross R.K., and Yu M.C. Absence of the glutathione S-transferase M1 gene increases cytochrome P4501A2 activity among frequent consumers of cruciferous vegetables in a Caucasian population. Cancer Epidemiol Biomarkers Prev 7 7 (1998) 635-638
54. Lampe J.W., King I.B., Li S., Grate M.T., Barale K.V., Chen C., et al. Brassica vegetables increase and apiaceous vegetables decrease cytochrome P450 1A2 activity in humans: changes in caffeine metabolite ratios in response to controlled vegetable diets. Carcinogenesis 21 6 (2000) 1157-1162
55. Lampe J.W., Chen C., Li S., Prunty J., Grate M.T., Meehan D.E., et al. Modulation of human glutathione S-transferases by botanically defined vegetable diets. Cancer Epidemiol Biomarkers Prev 9 8 (2000) 787-793
56. Burchell B. Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation. Am J Pharm 3 1 (2003) 37-52
57. Maruo Y., Iwai M., Mori A., Sato H., and Takeuchi Y. Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Curr Drug Metab 6 2 (2005) 91-99
58. Boersma M.G., van der Woude H., Bogaards J., Boeren S., Vervoort J., Cnubben N.H., et al. Regioselectivity of phase II metabolism of luteolin and quercetin by UDP-glucuronosyl transferases. Chem Res Toxicol 15 5 (2002) 662-670
59. Doerge D.R., Chang H.C., Churchwell M.I., and Holder C.L. Analysis of soy isoflavone conjugation in vitro and in human blood using liquid chromatography-mass spectrometry. Drug Metab Dispos 28 3 (2000) 298-307
60. King C.D., Rios G.R., Green M.D., and Tephly T.R. UDP-glucuronosyltransferases. Curr Drug Metab 1 2 (2000) 143-161
61. Innocenti F., Undevia S.D., Iyer L., Chen P.X., Das S., Kocherginsky M., et al. Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan. J Clin Oncol 22 8 (2004) 1382-1388
62. Peters U., Sinha R., Bell D.A., Rothman N., Grant D.J., Watson M.A., et al. Urinary mutagenesis and fried red meat intake: influence of cooking temperature, phenotype, and genotype of metabolizing enzymes in a controlled feeding study. Environ Mol Mutagen 43 1 (2004) 53-74
63. Chung T.W., Lee D.I., Kim D.S., Jin U.H., Park C., Kim J.G., et al. Molecular cloning and characterization of a large subunit of Salmonella typhimurium glutamate synthase (GOGAT) gene in Escherichia coli. J Microbiol 44 3 (2006) 301-310
64. Sun D., Chen G., Dellinger R.W., Duncan K., Fang J.L., and Lazarus P. Characterization of tamoxifen and 4-hydroxytamoxifen glucuronidation by human UGT1A4 variants. Breast Cancer Res 8 4 (2006) R50
65. Pai T.G., Suiko M., Sakakibara Y., and Liu M.C. Sulfation of flavonoids and other phenolic dietary compounds by the human cytosolic sulfotransferases. Biochem Biophys Res Commun 285 5 (2001) 1175-1179
66. Ronis M.J., Little J.M., Barone G.W., Chen G., Radominska-Pandya A., and Badger T.M. Sulfation of the isoflavones genistein and daidzein in human and rat liver and gastrointestinal tract. J Med Food 9 3 (2006) 348-355
67. Nowell S., and Falany C.N. Pharmacogenetics of human cytosolic sulfotransferases. Oncogene 25 11 (2006) 1673-1678